Potassium Nitrate

CHEMBL1644029 Phase 4 ได้รับการอนุมัติ Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
101.1 g/mol
LogP
Phase
4

Potassium nitrate is an inorganic salt that can act as a nitrate donor, being metabolized to nitrite and subsequently to nitric oxide, which causes vasodilation of blood vessels through activation of soluble guanylate cyclase and smooth muscle relaxation. It has been used historically as an antihypertensive and antianginal agent, and topically in desensitizing toothpastes for dentinal hypersensitivity through occlusion of dentinal tubules.

น้ำหนักโมเลกุล

101.1030 g/mol

TPSA

62.90 Ų

ด้านการรักษา

กลไกการออกฤทธิ์

Applied directly to the skin or mucous membranes, where it exerts its therapeutic effect locally at the site of application with minimal systemic absorption.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

กลไก

Applied directly to the skin or mucous membranes, where it exerts its therapeutic effect locally at the site of application with minimal systemic absorption.

โครงสร้าง 2 มิติ

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

O=[N+]([O-])[O-].[K+]

InChI

InChI=1S/K.NO3/c;2-1(3)4/q+1;-1

Molecular Formula

KNO3

HBD / HBA

- / 3

พันธะที่หมุนได้

0

อะตอมหนัก

5

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

คำถามที่พบบ่อย

Potassium nitrate is an inorganic salt that can act as a nitrate donor, being metabolized to nitrite and subsequently to nitric oxide, which causes vasodilation of blood vessels through activation of soluble guanylate cyclase and smooth muscle relaxation. It has been used historically as an antihypertensive and antianginal agent, and topically in desensitizing toothpastes for dentinal hypersensitivity through occlusion of dentinal tubules.

Applied directly to the skin or mucous membranes, where it exerts its therapeutic effect locally at the site of application with minimal systemic absorption.

Yes, Potassium Nitrate is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1644029. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 24434. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

ข้อจำกัดความรับผิดชอบทางการแพทย์

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.